These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15885835)

  • 1. A new scaleable method for the purification of botulinum neurotoxin type E.
    Gessler F
    J Biotechnol; 2005 Sep; 119(2):204-11. PubMed ID: 15885835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and purification of Clostridium botulinum type C and D neurotoxin.
    Gessler F; Böhnel H
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):361-7. PubMed ID: 10397323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity.
    Sayadmanesh A; Ebrahimi F; Hajizade A; Rostamian M; Keshavarz H
    Iran Biomed J; 2013; 17(4):165-70. PubMed ID: 23999711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A; Alam SI; Dhaked RK; Singh L
    Indian J Med Res; 2006 Sep; 124(3):355-62. PubMed ID: 17085839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B [corrected].
    Zhao Y; Kang L; Gao S; Gao X; Xin W; Wang J
    PLoS One; 2012; 7(6):e39670. PubMed ID: 22761863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.
    Watanabe T; Sagane Y; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Oct; 18(7):753-60. PubMed ID: 10691185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of type E botulinum neurotoxin by high-performance ion exchange chromatography.
    Schmidt JJ; Siegel LS
    Anal Biochem; 1986 Jul; 156(1):213-9. PubMed ID: 3740411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor-binding domain of botulinum neurotoxin serotype D.
    Zhang Y; Gao X; Qin L; Buchko GW; Robinson H; Varnum SM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Dec; 66(Pt 12):1610-3. PubMed ID: 21139207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive detection of botulinum neurotoxin types C and D with an immunoaffinity chromatographic column test.
    Gessler F; Hampe K; Böhnel H
    Appl Environ Microbiol; 2005 Dec; 71(12):7897-903. PubMed ID: 16332765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastoris.
    Dux MP; Huang J; Barent R; Inan M; Swanson ST; Sinha J; Ross JT; Smith LA; Smith TJ; Henderson I; Meagher MM
    Protein Expr Purif; 2011 Feb; 75(2):177-85. PubMed ID: 20933089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.
    Potter KJ; Bevins MA; Vassilieva EV; Chiruvolu VR; Smith T; Smith LA; Meagher MM
    Protein Expr Purif; 1998 Aug; 13(3):357-65. PubMed ID: 9693060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.
    Wadsworth JD; Desai M; Tranter HS; King HJ; Hambleton P; Melling J; Dolly JO; Shone CC
    Biochem J; 1990 May; 268(1):123-8. PubMed ID: 2188647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.
    Dekleva ML; Dasgupta BR
    J Bacteriol; 1990 May; 172(5):2498-503. PubMed ID: 2185224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and amino acid composition of type E botulinum neurotoxin.
    DasGupta BR; Rasmussen S
    Toxicon; 1983; 21(4):535-45. PubMed ID: 6353669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.